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Abstract
The method to induce unilateral cryogenic lesions was first described in 1958 by Klatzo. We describe here an
adaptation of this model that allows reliable measurement of lesion volume and vasogenic edema by 2, 3, 5-
triphenyltetrazolium chloride-staining and Evans blue extravasation in mice. A copper or aluminium cylinder with a
tip diameter of 2.5 mm is cooled with liquid nitrogen and placed on the exposed skull bone over the parietal
cortex (coordinates from bregma: 1.5 mm posterior, 1.5 mm lateral). The tip diameter and the contact time
between the tip and the parietal skull determine the extent of cryolesion. Due to an early damage of the blood
brain barrier, the cryogenic cortical injury is characterized by vasogenic edema, marked brain swelling, and
inflammation. The lesion grows during the first 24 hours, a process involving complex interactions between
endothelial cells, immune cells, cerebral blood flow, and the intracranial pressure. These contribute substantially to
the damage from the initial injury. The major advantage of the cryogenic lesion model is the circumscribed and
highly reproducible lesion size and location.
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Introduction
Traumatic brain injury (TBI) and its sequel represent a
major cause of disability and death worldwide [1]. TBI
consists of the primary irreversible damage and a multi-
tude of secondary cascades, resulting progressively in
tissue degeneration and neurological impairment [2-4].
The outcome of severe cerebral lesion does not solely
depend on the primary damage, but on the extent of
secondary lesions.
Several models of experimental traumatic brain injury
have been developed in an attempt to reproduce differ-
ent aspects of the biomechanical impairments and neu-
rological deficits observed in human head injury. The
fluid percussion model produces brain injury by rapid
injection of fluid into the closed cranial cavity [5,6]. The
controlled cortical impact trauma is induced by using a
pneumatic impactor to impact exposed brain with a
measurable, controllable impact speed and cortical
deformation [7]. In comparison to these two models of
focal TBI, the unilateral cryogenic lesion model first
described in 1958 by Klatzo [8] induces lesions that are
well circumscribed and highly reproducible in size and
location. Due to an early damage of the blood brain bar-
rier (BBB), the cryogenic cortical injury leads to vaso-
genic edema, marked brain swelling, and inflammation.
The histological and pathological features of cryogenic
lesions share many of the hallmark characteristics of
human TBI [9,10]. For example, upregulation of inflam-
matory cytokine expression is detected by real-time PCR
as early as 24 h after cryogenic lesion [11]. The cryo-
genic lesion model can further be used to study long
term neurodegenerative changes similar to late compli-
cations of human head injury such as global brain atro-
phy, cognitive impairment, and behavioural
abnormalities [12,13]. Furthermore, cryogenic cortical
injury has been shown to lead to late brain atrophy and
impairment of spatial memory, two key readout para-
meters for late consequences of TBI [12]. Yet another
advantage of the cryogenic model is its technical simpli-
city as craniotomy is not required.
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Material
Experimental equipment
1. Ketanest-S 25 mg/ml (S-ketamine hydrochloride) and
Rompun 2% (xylazine)
2. Stereotaxic device (TSE Systems GmbH, Bad Hom-
burg) depicted in Figure 1
3. Liquid nitrogen, Cotton-tipped applicators, 3-0 Silk
sutures
4. Cone-shaped copper or aluminium cylinder with tip
diameter of 2.5 mm and a body coated with polystyrene
(Figure 2)
5. Heating device
Setup of surgery and 2, 3, 5-triphenyltetrazolium chloride
-staining
1. Scalpel (optional)
2. Scissors (e.g., delicate curved sharp/blunt iris scis-
sors, Fine Science Tools Inc., Foster City, CA)
3. Forceps: One pair of splinter forceps (e.g., 90 mm
curved splinter forceps, Aesculap AG, Tuttlingen,
Germany)
4. Needle holder (e.g., Halsey Micro Needle Holder,
Fine Science Tools)
5. Mouse brain matrix (e.g., mouse brain slicer matrix
with 1 mm coronal slice intervals, Harvard Apparatus,
Holliston, MA, USA)
6. Razor blade (e.g., SIH1 razor blades, Hartenstein
Laborbedarf, Würzburg, Germany)
7. Phosphate-buffered saline (PBS)
8. 2, 3, 5-triphenyltetrazolium chloride (TTC) (e.g.,
Sigma-Aldrich, St. Louis, MO)
9. 2% Evans blue (Sigma)
9. ImageJ software (National Institutes of Health,
USA) for planimetric calculation of lesion volumes
10. 4% paraformaldehyde, NaCl
Methods
All animal experiments have to be conducted in accor-
dance with the laws and regulations of the regulatory
authorities for animal care, and they require an appro-
priate animal experimentation facility. Due to substantial
strain and gender variations in mice, those crucial para-
meters are not interchangeable. In our laboratory, we
use male, pathogen-free C57BL/6 mice (8-11 weeks) and
genetically manipulated mice on a C57BL/6 background.
Surgery
1. Anaesthesia with an intraperitoneal injection of
Ketanest-S 25 mg/ml and Rompun 2% in a dose of 0.1
mg/g ketamine and 0.005 mg/g xylazine. The depth of
surgical anaesthesia is verified before starting surgery.
2. 3-point rigid cranial fixation in stereotaxic device as
depicted in Figure 3.
3. A midline sagittal scalp incision is made in the mid-
line of the head (Figure 3).
4. The target area for lesion is on the right parietal
skull, coordinates from bregma: 1.5 mm posterior, 1.5
mm lateral (Figure 4).
5. A cone-shaped copper or aluminium cylinder with a
tip diameter of 1.5 or 2.5 mm will be filled with liquid
nitrogen (-196°C) and placed stereotactically on the
right parietal skull (coordinates as described) for definite
time (60, 90, or 120 secs) (Figure 5). An extended con-
tact time and more tip diameter range will increase the
lesion volume. Sham-operated animals go through theFigure 1 Stereotaxic device.
Figure 2 Cone-shaped copper cylinder with tip diameter of 2.5
mm.
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same procedure without cooling the cylinder with liquid
nitrogen.
6. The cone-shaped copper or aluminium cylinder is
removed.
7. Wound closure by standard skin suture using a nee-
dle holder and, e.g., 3-0 Ethilon suture material (Figure
6).
The time required for surgery is usually 5-10 min.
Outcome
Key readout parameters include the assessment of lesion
size and the magnitude of blood brain barrier
breakdown.
Determination of lesion size
The cortical lesions increase over the first 24 h
because the penumbral area surrounding the cryogenic
cortical lesion is subsequently involved in the definite
lesion area. 24 h after cryogenic cortical lesion induc-
tion, the brains are removed and sliced up into 2-mm-
thick sections according to the coronal plane using a
mouse brain slice matrix (Harvard Apparatus,
Holliston, MA, USA). The slices are immersed in 2%
TTC in PBS to visualize the lesion size (Figure 7).
According to the calculated lesion areas with the
known slice thickness lesion volumes can be measured
planimetrically [11].
Determination of blood brain barrier permeability
Commonly occurring vasogenic edema formation, as
sequel of breakdown of the BBB after traumatic brain
injury, is one of the most important intracranial causes
for secondary brain damage, leading to an increased
intracranial pressure, causing brain shift, and at last
brain herniation [14].
Further important read out criteria within this animal
model is the assessment of the cerebral vasculature per-
meability after breakdown of the BBB to evaluate the
traumatic vasogenic edema formation. This procedure
Figure 3 3-point rigid cranial fixation in stereotaxic device. A
midline sagittal scalp incision is made to expose the skull bone.
Figure 4 Focal brain lesion coordinates from bregma: 1.5 mm
posterior and 1.5 mm lateral.
Raslan et al. Experimental & Translational Stroke Medicine 2012, 4:6
http://www.etsmjournal.com/content/4/1/6
Page 3 of 5
can be easily and reliable investigated in the cryogenic
cortical lesion model. 2% Evan’s Blue tracer diluted in
0.9% NaCl is intravenously injected 2 h and 24 h after
the induction of the cryogenic brain lesion. After 24 h
the mice are killed with an overdose of the anesthetic
and were transcardially perfused with 4% paraformalde-
hyde, the brains are removed and sliced up into 2-mm-
thick sections according to the coronal plane using a
mouse brain slice matrix. Planimetric measurements of
the brain parenchyma stained with Evan’s Blue (Figure
8) are used to calculate edema volumes [15]. According
to the calculated lesion areas with the known slice thick-
ness lesion volumes can be measured planimetrically
[11,16].
The pearls and pitfalls of the cryogenic lesion models
are listed below.
Advantages:
• highly standardized lesion size and location
• lesion volume on TTC is a reliable readout
Figure 5 Cone-shaped aluminium cylinder (tip diameter 2.5
mm) is filled with liquid nitrogen (-196°C) and placed on the
right parietal skull coordinates as described in figure 4).
Figure 6 Standard skin suture using, e.g., a needle holder and
3,0 Ethilon suture material.
Figure 7 Representative images of 2,3,5-triphenyltetrazolium
chloride (TTC)-stained coronal brain sections from wild-type
mice, two mice after cryogenic brain lesion (left) and one
mouse after sham lesion (right) 24 h after cryogenic cortical
injury or sham operation. Planimetric measurements of lesion
volumes are given for each case.
Figure 8 Evan’s Blue staining to assess the magnitude of the
breakdown of the blood brain barrier after cryogenic injury.
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• pronounced vasogenic edema and breakdown of the
blood brain barrier that can easily be quantified by
Evans blue extravasation
• technical simplicity, does not require craniotomy
• easily adaptable for mice
Disadvantages:
• not a mechanical trauma
• no counter coup, diffuse axonal injury or postcontu-
sional bleeding
Summary
Unilateral cryogenic brain lesion in mice with subse-
quent focal brain lesion and breakdown of the BBB is a
valid model to investigate the histological and pathologi-
cal characteristics of brain trauma and develop novel
therapeutic strategies to reduce neuronal cell death and
vasogenic brain edema [11]. Clinically relevant readouts
that can be used for testing of new therapies in this
model include lesion size, vasogenic edema, and
inflammation.
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